In this conversation moderated by Vera Mucaj, Head of Trials and Chief Scientist at Datavant, our panelists will share how they’re thinking about current trends and future needs in oncology and RWD.
Use RWD endpoints in oncology clinical development and beyond and consider the use of novel data sources (e.g., genomic data).
Learn about the role of RWD in step-change innovation across the oncology clinical development and commercial lifecycle (e.g., seamless trials, increased diversity in recruitment, improving patient access).